glp 1 agonist retatrutide for weight loss: Study shows 30% body weight loss Retatrutide vs. Ozempic

Top-selling drug charts in 2025H1 show GLP-1 agonists displacing traditional blockbusters, reflecting how obesity and diabetes treatments have become huge revenue drivers

Yet, a deeper understanding of GLP-1s role in T1DM treatment demands further study

doi: 10.2337/dc24-S009

CagriSema (cagrilintide/semaglutide) Pending Approval - A combination injectable medication in development, combining cagrilintide and semaglutide to enhance weight loss through appetite suppression

GLP-1 medications slow gastric emptying, meaning food and liquids remain in the stomach longer than normal

And even when physicians are prescribing GLP-1RAs for their intended uses, its not a magic formula there are complex considerations such as dosages, costs, side effects and comparisons between specific drugs